PLoS ONE · 2013 · 19 citations · 34 references
MedicinePharmacokineticsPharmacologyDrug MetabolismPharmacogeneticsPharmacogenomicsBinding Affinity PredictionCytochrome P450 EnzymesCytochrome P450 InteractionsCytochrome P450-mediated MetabolismMetabolism ModelingMetabolism VariabilityCytochrome P450 2C9Cytochrome P450 Genetic PolymorphismCytochrome P450 Interaction ModelingCytochrome P450 ModelingCytochrome P450 Structure-function RelationshipsHydroxylationMetabolic Enzyme Activity DifferencesSystem Model Development
Cytochrome P450 2C9 (CYP2C9) is crucial in excretion of commonly prescribed drugs. However, changes in metabolic activity caused by CYP2C9 polymorphisms inevitably result in adverse drug effects. CYP2C9*2 and *3 are prevalent in Caucasian populations whereas CYP2C9*13 is remarkable in Asian populations. Single amino acid substitutions caused by these mutations are located outside catalytic cavity but affect kinetic activities of mutants compared to wild-type enzyme. To relate distal effects of these mutations and defective drug metabolisms, simulations of CYP2C9 binding to anti-coagulant (S)-warfarin were performed as a system model. Representative (S)-warfarin-bound forms of wild-type and mutants were sorted and assessed through knowledge-based scoring function. Interatomic interactions towards (S)-warfarin were predicted to be less favorable in mutant structures in correlation with larger distance between hydroxylation site of (S)-warfarin and reactive oxyferryl heme than wild-type structure. Using computational approach could delineate complication of CYP polymorphism in management of drug therapy.
34
Python: a programming language for software integration and development.
M F Sanner · PubMed · 1999 · 3.1K citations
University of California, San Francisco
Medical History · 1974 · 2.2K citations · Full text
A semiempirical free energy force field with charge‐based desolvation
Ruth Huey, Garrett M. Morris, Arthur J. Olson et al. · Journal of Computational Chemistry · 2007 · 2.2K citations · Full text